HK Stock Market Move | BRAINAURORA-B (06681) plunged nearly 20% from a high in late trading, with an intraday amplitude of as much as 42%
BRAINAURORA-B (06681) retreated sharply in late trading, plunging more than 19%. As of press time, it fell 19.23% to HK$1.47, with a turnover of HK$1.481 billion.
BRAINAURORA-B (06681) fell sharply in late trading, dropping over 19%. As of press time, it was down 19.23% at HK$1.47, with a turnover of HK$1.481 billion.
On the news front, on October 28, BrainAurora announced that its self-developed depression cognitive function assessment software had obtained a Class II medical device registration certificate, becoming China's first "depression cognitive assessment" medical device product registration certificate. This marks a major breakthrough in the field of cognitive assessment for mental illness and also marks further improvement in BrainAurora's layout of digital therapeutic products for cognitive impairment.
BrainAurora's share price has recently surged continuously on heavy volume, soaring over 50% in a single day yesterday, with intraday gains once expanding to over 20% in the afternoon before a rapid plunge, with a full-day amplitude of as much as 42%. In addition, among the stocks on the Stock Connect active trading list on October 28, BrainAurora made the list for the first time in nearly a month.
Related Articles

GREENTOWN SER (02869) repurchased 238,000 shares for HK$949,800 on October 29.

RECBIO-B(02179) Receives Phase III Clinical Trial Summary Report for Novel Adjuvanted Recombinant Herpes Zoster Vaccine REC610

HAOHAI BIOTEC (06826) repurchased 16,900 shares for HK$271,100 on October 29.
GREENTOWN SER (02869) repurchased 238,000 shares for HK$949,800 on October 29.

RECBIO-B(02179) Receives Phase III Clinical Trial Summary Report for Novel Adjuvanted Recombinant Herpes Zoster Vaccine REC610

HAOHAI BIOTEC (06826) repurchased 16,900 shares for HK$271,100 on October 29.






